[PROLOGO: efalizumab].
Vanaclocha Sebastián
F
F
Servicio de Dermatología, Hospital Universitario 12 de Octubre, Madrid, España.
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D001688:Biological Products / Q000627:therapeutic use*; D040881:CD11a Antigen / Q000276:immunology; D002986:Clinical Trials as Topic; D003879:Dermatologic Agents / Q000627:therapeutic use*; D006801:Humans; D011565:Psoriasis / Q000628:therapy*
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D001688:Biological Products; D040881:CD11a Antigen; D003879:Dermatologic Agents; C472181:efalizumab